Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters








Database
Language
Publication year range
1.
Acta Neurol Scand ; 114(2): 97-101, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16867031

ABSTRACT

OBJECTIVE: The aim of this article was to evaluate the effects of amisulpride on the behavioural and psychiatric symptoms of patients with Alzheimer's disease (AD). MATERIALS AND METHODS: In this open-label study, we observed 18 outpatients affected by moderate to severe AD, complicated with agitation and disruptive behaviours. Behavioural, cognitive and motor effects of amisulpride at baseline and after 12 weeks were rated by the Neuropsychiatric Inventory (NPI), Mini Mental State Examination, Clinical Dementia Rating Scale, activities of daily living, and the motor score of the Unified Parkinson's Disease Rating Scale. RESULTS: After treatment with amisulpride (200 mg/day), the patients showed a significant decrease in NPI total scores, particularly for the subitem 'agitation'. Cognitive and motor variables did not worsen significantly over the 12-week period. CONCLUSIONS: This preliminary observation suggests that amisulpride can be useful to control agitation and disruptive behaviours in AD patients without significantly effecting vigilance and motor activity.


Subject(s)
Alzheimer Disease/complications , Antipsychotic Agents/administration & dosage , Mental Disorders/drug therapy , Mental Disorders/etiology , Sulpiride/analogs & derivatives , Aged , Aged, 80 and over , Aggression/drug effects , Alzheimer Disease/psychology , Amisulpride , Anxiety Disorders/drug therapy , Anxiety Disorders/etiology , Anxiety Disorders/psychology , Arousal/drug effects , Cognition/drug effects , Female , Humans , Irritable Mood/drug effects , Male , Mental Disorders/psychology , Motor Activity/drug effects , Neuropsychological Tests , Psychomotor Agitation/drug therapy , Psychomotor Agitation/etiology , Psychomotor Agitation/psychology , Schizophrenia, Paranoid/drug therapy , Schizophrenia, Paranoid/etiology , Schizophrenia, Paranoid/psychology , Sulpiride/administration & dosage , Treatment Outcome
2.
J Headache Pain ; 6(6): 477, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16388348

ABSTRACT

Spontaneous intracranial hypotension is a well defined entity, however it is characterised by a relevant clinical heterogeneity. The main feature is orthostatic headache, often accompanied by other symptoms. The diagnosis is easily made in the presence of orthostatic headache, excluding an obvious aetiology of low cerebrospinal fluid (CSF) pressure, and often there is no evidence of direct or indirect CSF leak.


Subject(s)
Intracranial Hypotension/physiopathology , Adult , Anti-Inflammatory Agents/therapeutic use , Cerebrospinal Fluid Pressure/physiology , Female , Headache/etiology , Humans , Intracranial Hypotension/cerebrospinal fluid , Intracranial Hypotension/complications , Magnetic Resonance Imaging , Methylprednisolone/therapeutic use , Posture/physiology
SELECTION OF CITATIONS
SEARCH DETAIL